Riskpilot← Back to searchSign inGet full accessDANSK FARMACEUTISK INDUSTRI A/S
A/SActiveCVR 10224675Dam Enge 4Wholesale of other food · NACE 4638Est. 19868 employees
Revenue 2025
DKK 17,6M
-4% vs 2024
EBITDA margin
76.5%
-9% vs 2024
Equity ratio
57.1%
Financial strength
Net profit 2025
DKK 10,5M
-6% vs 2024
| Revenue | DKK 17,6M | -4% |
| EBITDA | DKK 13,5M | -9% |
| Net profit | DKK 10,5M | -6% |
| Total assets | DKK 24,8M | +5% |
| Equity | DKK 14,2M | +4% |
| Employees | 8 | — |
Legal name
DANSK FARMACEUTISK INDUSTRI A/S
CVR number
10224675
Legal form
Aktieselskab
NACE code
4638 · Wholesale of other food
Founded
1. maj 1986
Share capital
DKK 2.400.000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af den samlede bestyrelse
Company purpose
Selskabets formål er at drive handel og industri
Address
Dam Enge 4
Phone
+4544860550
Email
dfi@dkpharma.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.867 | 5.889 | 8.225 | 8.154 | 11.580 | 11.263 | 12.141 | 13.992 | 11.420 | 20.799 | 15.437 | 12.266 | 18.406 | 17.633 |
| Staff expenses | -3.158 | -3.748 | -3.904 | -3.063 | -5.013 | -4.210 | -4.683 | -5.189 | -3.901 | -3.527 | -4.561 | -5.384 | -3.556 | -4.138 |
| EBITDA | 1.709 | 2.141 | 4.322 | 5.091 | 6.567 | 7.053 | 7.457 | 8.803 | 7.519 | 17.243 | 10.876 | 6.663 | 14.850 | 13.495 |
| Depreciation & amort. | -510 | -489 | -502 | -489 | -240 | -261 | -147 | -413 | -510 | -340 | -216 | -175 | -142 | -15 |
| EBIT | 1.200 | 1.652 | 3.820 | 4.602 | 6.327 | 6.793 | 7.310 | 8.390 | 7.009 | 16.903 | 10.660 | 6.488 | 14.708 | 13.480 |
| Net financials | -167 | -77 | 20 | 432 | -394 | 8 | -10 | 70 | 22 | -93 | -1.268 | -298 | -363 | 20 |
| Profit before tax | 1.033 | 1.575 | 3.840 | 5.033 | 5.934 | 6.800 | 7.301 | 8.460 | 7.030 | 16.810 | 9.391 | 6.190 | 14.345 | 13.500 |
| Tax | 260 | 394 | 942 | 1.185 | 1.307 | 1.509 | 1.617 | 1.864 | 1.548 | 3.702 | 2.075 | 1.368 | 3.159 | 2.977 |
| Net profit | 773 | 1.181 | 2.898 | 3.848 | 4.627 | 5.291 | 5.684 | 6.597 | 5.482 | 13.108 | 7.316 | 4.822 | 11.186 | 10.523 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9.262 | 9.170 | 12.971 | 14.969 | 19.020 | 15.652 | 19.405 | 22.898 | 28.946 | 35.811 | 45.831 | 49.810 | 23.744 | 24.828 |
| Equity | 4.502 | 5.183 | 7.081 | 9.429 | 12.556 | 9.547 | 9.231 | 10.127 | 9.009 | 16.618 | 10.634 | 7.456 | 13.642 | 14.165 |
| Long-term debt | 0 | 44 | 0 | 0 | 1.245 | 1.522 | 1.500 | 1.915 | 1.548 | 3.618 | 2.252 | 1.431 | 3.164 | 2.957 |
| Short-term debt | 4.733 | 3.970 | 5.890 | 5.540 | 5.156 | 4.534 | 8.510 | 10.742 | 18.276 | 15.379 | 32.926 | 40.923 | 6.938 | 7.706 |
| Total debt | 4.733 | 3.970 | 5.890 | 5.540 | 6.402 | 6.056 | 10.010 | 12.657 | 19.824 | 18.996 | 35.179 | 42.354 | 10.102 | 10.663 |
EBITDA margin
76.5%
This company
15.8%
Market median
+384% vs market
20122025
Equity ratio
57.1%
This company
38.2%
Market median
+49% vs market
20122025
Return on equity
74.3%
This company
18.4%
Market median
+304% vs market
20122025
Net profit margin
59.7%
This company
8.1%
Market median
+637% vs market
20122025
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20122025
Debt / equity
0.75×
This company
0.62×
Market median
+21% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VC Founder | Founder | 1986 | — | — |
PC Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
BA Audit | Audit | 1999 | — | — |
JP Management | Management | 1986 | — | — |
SB Founder | Founder | 1986 | — | — |
JN Founder | Founder | 1986 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 1986 | — | — | |
| Chairman | 1998 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 1986 | — | — | |
| Board of Directors | 1998 | — | — | |
| Board of Directors | 1986 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
INTER HOLDING BALLERUP ApS | Company | 100.0% | 100.0% | 1999 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Capobianco Holding ApS
DANSK FARMACEUTISK INDUSTRI A/S Board members of DANSK FARMACEUTISK INDUSTRI A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Victor Christoffersen | Founder | 0 companies |
| Patrick Capobianco Lyndrup | Chief Executive Officer | 0 companies |
| Bjarne Anker Baymler | Audit | 0 companies |
| Jørgen Pedersen | Management | 0 companies |
| Søren Bonde | Founder | 0 companies |
| Jens Nørskov | Founder | 0 companies |
| Gitte Pedersen | Chairman | 0 companies |
| Isabella Capobianco | Board of Directors | 0 companies |
| Ane-Lise Birch Pedersen | Board of Directors | 0 companies |
| Lone Pedersen | Chairman | 0 companies |
| Marco Capobianco | Board of Directors | 0 companies |
| Hans Matthiesen | Board of Directors | 0 companies |
| Mette Pedersen | Board of Directors | 0 companies |
| Aage Bruun | Board of Directors | 0 companies |